APOS Medical and Sports Technology Ltd., an Israeli firm, recently introduced that it has raised $eight million in enterprise capital funding for additive growth and advertising and marketing of its distinctive machine designed for degenerative joint disease remedy for knee ache victims. Pitango Venture Capital, a big VC agency additively positioned in Israel, made the funding. The VC agency has a historical past of investment in profitable know-how firms, with over 120 investments since 1993.
The APOS machine is designed to deal with knee degenerative joint disease by creating multi-directional instability. The machine appears to be like like a shoe with two half balls affixed to the only. APOS is an acronym for "All Phases of Step Cycle" and was developed by Dr. Avi Elbaz and Dr. Amit Mor in Israel. Development of the machine has been current for over 10 years.
The APOS machine, which incorporates the semispherical balls, is hooked up to a affected individual's footwear. The platform's balls create an unstable gait, mimicking pure strolling on uneven surfaces. While on the face of it odd, the instability each relieves ache and strengthens an individual's muscle mass. Patients use the APOS machine for 30 to 60 proceedings every day. As the affected individual makes use of the machine, the instability forces the affected individual's physique to a correct alignment, decreasing ache. Also, the particular individual's muscle mass are retrained, creating improved movement and elevated operate. The remedy is run by specifically educated physiotherapists, and consists of processed gait evaluation.
Clinical trials have well-tried that the machine improves the affected individual's posture and stroll, and relieves knee and different leg joint ache. The system was designed crosswise the idea of useful rehabilitation. The APOS machine simulates actual life circumstances, the place many present methods educate a affected individual to face in a clinic. APOS' designers tried to simulate the way in which mammals rehab in nature.
APOS has carried out trials which have well-tried the platform can
* cut back the depth of knee ache by 66% after eight weeks
* remove most decrease once again ache in 70% of sufferers
* improve affected individual's superiority of life by well enhancing joint operate
Drs. Elbaz and Mor have seen over twenty thousand sufferers up to now with the APOS machine. Half of the remedies had been carried call at Israel Additionally, in 2009, the corporate put together carried out a industrial trial inside the United Kingdom with Bupa, Britain's largest individualal medical health insurance company. As a results of the trial, the businesses intentional APOSTherapy, which is now a stand alone entity that could be a member of the Association of British Healthcare Industries.
Dr. Mor, APOS' CEO says, "The product has several applications. It can be used for stabilization, improve athletes' performance, and prevent knee injury." The machine also can deal with knee injury ascribable to acquiring older, or accidents from sports activities or accidents.
So far, APOS markets its product in Israel, Singapore, and the UK, the place it operates with Britain's largest individualal medical health insurance company BUPA Ltd. APOS intends to make use of the return from Pitango's funding to finance the launch of its machine in different international locations, particularly the US, Germany, and Japan. APOS is at the moment searching for US FDA approval.
0 Comments